Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

The tumour-associated antigen MAGE-1 is detectable in formalin-fixed paraffin sections of malignant melanoma

  • 34 Accesses

  • 3 Citations

Abstract

The MAGE-1 gene encodes a protein encompassing a HLA-A1-restricted target epitope for cytolytic T lymphocytes. Monoclonal antibodies directed against the MAGE-1 protein were tested for usage in immunohistology of routine pathology material. Seven formalinfixed, paraffin-embedded malignant melanomas were studied by the Avidin-Biotin complex (ABC) method with or without different antigen retrieval methods. Native, frozen tissues from the same tumours were used to validate the results by immunohistochemistry on frozen sections, by PCR for mRNA and by protein demonstration in tissue extracts using western blotting. Of 4 monoclonal antibodies tested, mAB 34B and mAB 77B were highly efficient in detecting MAGE-1 protein in deparaffinised sections with the regular ABC method after microwave pretreatment. In a series of an additional 28 patients 75% expressed MAGE-1, 50% in a substantial proportion. Follow-up studies in 6 patients indicate that the expression pattern remains stable but may change substantially within a short range. Immunohistology is thus a rapid and well-established method that might be used to select and monitor HLA-A1 positive patients with malignant melanoma and other candidate tumours for MAGE-1-directed immuno-therapy.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Amar Costesec A, Godelaine D, Stockert E, Van der Bruggen P, Beaufay H, Chen YT (1994) The tumor protein MAGE-1 is located in the cytosol of human melanoma cells. Biochem Biophys Res Commun 204:710–715

  2. 2.

    Brasseur F, Marchand M, Vanwijck R, Herin M, Lethe B, Chomez P, Boon T (1992) Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors (letter). Int J Cancer 52:839–841

  3. 3.

    Burrows SR, Fernan A, Argaet V, Suhrbier A (1993) Bystander apoptosis induced by CD8+ cytotoxic T cell (CTL) clones: implications for CTL lytic mechanisms. Int Immunol 5:1049–1058

  4. 4.

    Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by guadinium-thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159

  5. 5.

    Inoue H, Mori M, Honda M, Li J, Shibuta K, Mimori K, Ueo H, Akiyoshi T (1995) The expression of tumor-rejection antigen “MAGE” genes in human gastric carcinoma. Gastroenterology 109:1522–1525

  6. 6.

    Lüscher U, Filgueira L, Juretic A, Zuber M, Lüscher NJ, Heberer M, Spagnoli GC (1994) The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes. Int J Cancer 57:612–619

  7. 7.

    McLean I, Nakane PK (1974) Periodate-lysine-paraformaldehyde fixative — a new fixative for immunoelectron microscopy. J Histochem Cytochem 22:1077–1083

  8. 8.

    Moch H, Oberholzer M, Dalquen P, Wegmann W, Gudat F (1993) Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: Immunohistochemical findings. Virchows Arch [A] 423:19–27

  9. 9.

    Oaks MK, Hanson JJ, O'Malley DP (1994) Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter: implications for MAGE immunotherapy. Cancer Res 54:1627–1629

  10. 10.

    Patard JJ, Brasseur F, Gil Diez S, Radvanyi F, Marchand M, Francois P, Abi Aad A, Van Cangh P, Abbou CC, Chopin D, et al (1995) Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer 64:60–64

  11. 11.

    Rimoldi D, Romero P, Carrel S (1993) The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas [letter]. Int J Cancer 54:527–528

  12. 12.

    Romero P, Pannetier C, Herman J, Jongeneel CV, Cerottini JC, Coulie PG (1995) Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1. J Exp Med 182:1019–1028

  13. 13.

    Russo V, Traversari C, Verrecchia A, Mottolese M, Natali PG, Bordignon C (1995) Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy. Int J Cancer 64:216–221

  14. 14.

    Schultz-Thater E, Juretic A, Dellabona P, Lüscher U, Siegrist W, Harder F, Heberer M, Zuber M, Spagnoli GC (1994) MAGE-1 gene product is a cytoplasmic protein. Int J Cancer 59:435–439

  15. 15.

    Shichijo S, Hayashi A, Takamori S, Tsunosue R, Hoshino T, Sakata M, Kuramoto T, Oizumi K, Itoh K (1995) Detection of MAGE-4 protein in lung cancers. Int J Cancer 64:158–165

  16. 16.

    Shichijo S, Tsunosue R, Masuoka K, Natori H, Tamai M, Miyajima J, Sagawa K, Itoh K (1995) Expression of the MAGE gene family in human lymphocytic leukemia. Cancer Immunol Immunother 41:90–103

  17. 17.

    Toh Y, Yamana H, Shichijo S, Fujita H, Tou U, Sakaguchi M, Kakegawa T, Itoh K (1995) Expression of MAGE-1 gene by esophageal carcinomas. Jpn J Cancer Res 86:714–717

  18. 18.

    Traversari C, Van der Bruggen P, Luescher IF, Lurquin C, Chomez P, Van Pel A, De Plaen E, Amar-Costesec A, Boon T (1992) A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 176:1453–1457

  19. 19.

    Van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643–1647

  20. 20.

    Weynants P, Lethe B, Brasseur F, Marchand M, Boon T (1994) Expression of mage genes by non-small-cell lung carcinomas. Int J Cancer 56:826–829

Download references

Author information

Correspondence to F. Gudat.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gudat, F., Dürmüller, U., Zuber, M. et al. The tumour-associated antigen MAGE-1 is detectable in formalin-fixed paraffin sections of malignant melanoma. Vichows Archiv A Pathol Anat 429, 77–81 (1996). https://doi.org/10.1007/BF00192428

Download citation

Key words

  • Malignant melanoma
  • MAGE-1
  • Immunohistology
  • Tumour antigen
  • Tumour markers
  • Biological immunology